Published June 2, 2026 | Version v1
Other Open

What evidence supports biological therapy, aside from anti-TNF therapy, for ileal Crohn's disease with perianal disease?

Authors/Creators

  • 1. Tripdatabase

Description

While anti-TNF therapy is a mainstay for Crohn's disease, other biological treatments such as ustekinumab, guselkumab, mirikizumab, and upadacitinib show promise for Ileal Crohn's disease with perianal involvement.

Files

b16ebccc-91a2-4164-96c5-984a41c2d7a6.pdf

Files (18.5 kB)

Name Size Download all
md5:bed7354bf8226dd4fc77f8bb49a09d65
18.5 kB Preview Download

Additional details